Desmoid Tumor and Pregnancy: Effect of Pregnancy on Disease Control and Effect of Diagnosis on Pregnancy History.

NCT05284305 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2023-01-27

No results posted yet for this study

Summary

Desmoid tumors (DT) are rare disease of intermediate malignancy with variable and often unpredictable clinical course. There is a growing interest in defining potential risk of recurrence or progression during or after pregnancy and in identifying potential obstetrical risks and infertility rate of desmoid patients.

Aim of the study:

* to define the impact of pregnancy on diagnosis, progression and recurrence of DT;
* to define the risks related to DT of obstetrical risks and decisions to interrupt or avoid pregnancy after the diagnosis of DT.

Conditions

  • Desmoid
  • Desmoid; Abdominal
  • Pregnancy Loss
  • Pregnancy Complications

Interventions

OTHER

Pregnancy

DT with a history of concomitant or subsequent pregnancy.

Sponsors & Collaborators

  • University of Padova

    collaborator OTHER
  • Institut Curie

    collaborator OTHER
  • Dana-Farber/Brigham and Women's Cancer Center

    collaborator OTHER
  • Mount Sinai Hospital, Canada

    collaborator OTHER
  • Desmoid Foundation Italia

    collaborator UNKNOWN
  • Istituto Oncologico Veneto IRCCS

    collaborator OTHER
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

    lead OTHER

Principal Investigators

  • Marco Fiore, MD · Fondazione IRCSS Istituto Nazionale Tumori

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2023-04-30
Completion
2023-05-15

Countries

  • United States
  • Canada
  • France
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05284305 on ClinicalTrials.gov